James Yu

James Yu

Yale University

H-index: 55

North America-United States

About James Yu

James Yu, With an exceptional h-index of 55 and a recent h-index of 42 (since 2020), a distinguished researcher at Yale University, specializes in the field of Radiation Oncology.

His recent articles reflect a diverse array of research interests and contributions to the field:

MGMT promoter methylation in 1p19q-intact gliomas

The immune regulatory function of B7-H3 in malignancy: spotlight on the IFN-STAT1 axis and regulation of tumor-associated macrophages

Patient-reported health-related quality of life (HRQoL) in the randomized FORMULA-509 trial of salvage radiotherapy and 6 months of GnRH agonist with either bicalutamide or …

Treating Chronic, Intractable Pain with a Miniaturized Spinal Cord Stimulation System: 1-Year Outcomes from the AUS-nPower Study During the COVID-19 Pandemic

External validation of the ARCAD nomogram in a real-world cohort of patients with stage IV colorectal cancer (CRC).

Progress in the treatment of anal cancer: an overview of the latest investigational drugs

Multiparametric MRI as a Predictor of PSA Response in Patients Undergoing Stereotactic Body Radiation Therapy for Prostate Cancer

Telehealth and Technology: New Directions in Cancer Care

James Yu Information

University

Position

Professor

Citations(all)

11925

Citations(since 2020)

7719

Cited By

6727

hIndex(all)

55

hIndex(since 2020)

42

i10Index(all)

140

i10Index(since 2020)

122

Email

University Profile Page

Yale University

Google Scholar

View Google Scholar Profile

James Yu Skills & Research Interests

Radiation Oncology

Top articles of James Yu

Title

Journal

Author(s)

Publication Date

MGMT promoter methylation in 1p19q-intact gliomas

Journal of Neuro-Oncology

Connor J Kinslow

Markus D Siegelin

Fabio M Iwamoto

Matthew Gallitto

Alfred I Neugut

...

2024/1

The immune regulatory function of B7-H3 in malignancy: spotlight on the IFN-STAT1 axis and regulation of tumor-associated macrophages

Robin Park

James Yu

Moazzam Shahzad

Sunggon Lee

Jong Dae Ji

2024/1/24

Patient-reported health-related quality of life (HRQoL) in the randomized FORMULA-509 trial of salvage radiotherapy and 6 months of GnRH agonist with either bicalutamide or …

Karen E Hoffman

Paul L Nguyen

Dana E Rathkopf

Amado J Zurita

Daniel Eidelberg Spratt

...

2024/2/1

Treating Chronic, Intractable Pain with a Miniaturized Spinal Cord Stimulation System: 1-Year Outcomes from the AUS-nPower Study During the COVID-19 Pandemic

Journal of Pain Research

John Salmon

Daniel Bates

Neels Du Toit

Paul Verrills

James Yu

...

2024/12/31

External validation of the ARCAD nomogram in a real-world cohort of patients with stage IV colorectal cancer (CRC).

James Yu

Jiannong Li

Michael Schell

Pablo Gonzalez Ginestet

John Raymond Zalcberg

...

2024/1/20

Progress in the treatment of anal cancer: an overview of the latest investigational drugs

James Yu

Richard D Kim

2024/2/1

Multiparametric MRI as a Predictor of PSA Response in Patients Undergoing Stereotactic Body Radiation Therapy for Prostate Cancer

Advances in Radiation Oncology

Kareem Rayn

Israel Deutsch

Brian Jeffers

Albert Lee

Elizaveta Lavrova

...

2024/3/1

Telehealth and Technology: New Directions in Cancer Care

James Yu

Carolyn Petersen

Sonya Reid

S Trent Rosenbloom

Jeremy L Warner

2024/1/1

Building on the past and creating a brave future: a message from the incoming editor in chief

James B Yu

2024/2/1

Updated Analysis of Comparative Toxicity of Proton and Photon Radiation for Prostate Cancer

Journal of Clinical Oncology

James B Yu

David M DeStephano

Brian Jeffers

David P Horowitz

Pamela R Soulos

...

2024/3

The Role of Targeted Radiation Therapy in the Treatment of Renal Cell Carcinoma

Albert Lee

Karie D Runcie

James B Yu

2024/1/1

Targeting Angiogenesis Alone and in Combination with Immune Checkpoint Inhibitors in Advanced Gastroesophageal Malignancies

Alireza Tojjari

Robin Park

James Yu

Anwaar Saeed

2024/1/31

Prognosis and risk of suicide after cancer diagnosis

Cancer

Connor J Kinslow

Prashanth Kumar

Mark Olfson

Melanie M Wall

Petros D Petridis

...

2024/2/15

Circulating tumor DNA analysis guiding adjuvant treatment in resected stage III cholangiocarcinoma: a case report

Journal of Gastrointestinal Oncology

James Yu

Trenton A Avriett

Christopher M Ray

Richard D Kim

2024

Biomarker Analysis from a Phase I/Ib Study of Regorafenib and Nivolumab in Mismatch Repair-Proficient Advanced Refractory Colorectal Cancer

Cancers

Dae Won Kim

Young-Chul Kim

Bence P Kovari

Maria Martinez

Ruoyu Miao

...

2024/1/28

Intensification of ADT with enzalutamide in high-risk patients with biochemical relapse following radical prostatectomy undergoing salvage radiation: Initial results from RTOG …

Edwin Melencio Posadas

Hiram Alberto Gay

Joseph P Rodgers

Todd Matthew Morgan

Ying Xiao

...

2024/2/1

Selected-Lesion SRS as a Novel Strategy in Treatment of Patients with Multiple Brain Metastases

International Journal of Radiation Oncology, Biology, Physics

C Singh

BC Theriault

Y An

JB Yu

JPS Knisely

...

2023/10/1

Development of Novel Monoclonal Antibodies Against Nattokinase

Scientific Reports

Maja G Rydahl

Stjepan K Kračun

Jonatan U Fangel

Gurvan Michel

Alexia Guillouzo

...

2017/8/24

EP041/# 178 PRE-MARKET CLINICAL EVALUATION OF A RECHARGEABLE SPINAL CORD STIMULATION DEVICE: EPOSTER VIEWING: AS07-PAIN PERSISTENT SPINAL PAIN SYNDROME (TYPE I AND II)

Neuromodulation

Paul Verrills

John Salmon

James Yu

Vahid Mohabbati

Frank Thomas

...

2023/12/1

ID: 214658 First-in-Human Experience With an Implantable SCS System With Automated Daily Remote Monitoring and Remote Programming

Neuromodulation

Marc Russo

James Yu

Vahid Mohabbati

Kasra Amirdelfan

Leonardo Kapural

...

2023/6/1

See List of Professors in James Yu University(Yale University)